Mediwhale to Present Late-Breaking Data on Retinal-AI–Driven Cardiovascular Disease Prevention at AHA 2025
At this year’s American Heart Association (AHA) Scientific Sessions, Mediwhale will showcase how our groundbreaking AI—already being used in real-world clinical settings—detects early signs of cardiovascular disease through the retina.
Late-Breaking Science
Session: Deep learning derived coronary artery calcium from retinal images for prediction of cardiovascular disease in two different cohorts: Multi-Ethnic Study of Atherosclerosis (MESA) and Rotterdam Study (MERO)
- Presenter: Sahil Thakur
- Location: Room No. 243
- Date: Fri, Nov 7
- Time: 4:15pm – 4:27pm CST
Moderated Posters
Session: Vascular Imaging for ASCVD Risk Stratification: Predictive Value of Carotid Plaque, Coronary Artery Calcium, and Retinal Biomarker (Dr.Noon CVD)
- Presenter: Chan Joo Lee
- Location: Population Science Zone
- Date: Sat, Nov 8
- Time: 2:41pm – 2:46pm CST
Session: Deep Learning-Based Retinal Biomarker Captures Cardiovascular Risk in Hypertensive Abnormal Dippers Beyond Conventional Metrics
- Presenter: Sahil Thakur
- Location: Population Science Zone
- Date: Mon, Nov 10
- Time: 12:43pm -12:48pm CST
Session: Retinal Vascular and Renal Biomarkers Predict Systemic Cardiovascular and Kidney Disease in the Brazilian Multilabel Ophthalmological Dataset (BRSET)
- Presenter: Sahil Thakur
- Location: Population Science Zone
- Date: Mon, Nov 10
- Time: 1:04pm – 1:09pm CST
Special Session / Invited Speaker
Session: Harnessing AI to Predict CKD Risk: A Game Changer in Early Detection
- Presenter: Young Su Joo
- Location: Rivergate
- Date: Sun, Nov 09
- Time:8:57am – 9:12am CST
Exhibition & Demo
Dr. Noon AI Screening Solutions (CVD Risk prediction) — Live demonstration
- Location: No. 4021
- Date: Sat to Mon, Nov 8 to 10
